Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts

  • Cho, ES; 
  • Yu, JH; 
  • Kim, MS; 
  • Yim, M
Citations

WEB OF SCIENCE

12
Citations

SCOPUS

13

초록

Phosphodiesterase (PDE) 4 inhibitors have been shown to induce the cAMP-mediated signaling pathway by inhibiting cAMP hydrolysis. This study investigated the effect of a PDE4 inhibitor on the expression of the inducible cAMP early repressor (ICER), which is an endogenous inhibitor of CRE-mediated transcription, in osteoblastic cells. RT-PCR analysis revealed that rolipram, a PDE4 inhibitor, stimulates the ICER mRNA in a dose dependent manner. The induction of ICER mRNA expression by rolipram was suppressed by the inhibitors of protein kinase A (PKA) and p38 MAPK, suggesting the involvement of PKA and p38 MAPK activation in ICER expression by rolipram. It was previously shown that rolipram induced the expression of TNF-related activation-induced cytokine (TRANCE, also known as RANKL, ODF, or OPGL) in osteoblasts. This paper provides evidences that a transcriptional repressor like ICER might modulate TRANCE mRNA expression by rolipram in osteoblasts.

키워드

osteoblast; cyclic AMP; PDE4 inhibitor; ICER; KAPPA-B LIGAND; PARATHYROID-HORMONE; PROTEIN-KINASE; MESSENGER-RNA; CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE; OSTEOCLAST DIFFERENTIATION; RECEPTOR ACTIVATOR; MC3T3-E1 CELLS; BONE; RAT
제목
Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts
저자
Cho, ES; Yu, JH; Kim, MS; Yim, M
DOI
10.3349/ymj.2005.46.1.149
발행일
2005-02
유형
Article
저널명
Yonsei Medical Journal
권
46
호
1
페이지
149 ~ 154